Lyra Therapeutics Inc (LYRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Operating Expenses | 7,053 | 6,363 | 4,545 | 4,248 | 4,388 |
| Operating Income | -7,053 | -6,363 | -4,545 | -4,248 | -4,388 |
| Other Income | 32 | 29 | 5 | 16 | 35 |
| Pre-tax Income | -7,021 | -6,334 | -4,540 | -4,232 | -4,353 |
| Net Income Continuous | -7,021 | -6,334 | -4,540 | -4,232 | -4,353 |
| Net Income | $-7,021 | $-6,334 | $-4,540 | $-4,232 | $-4,353 |
| EPS Basic Total Ops | 858.00 | -24.50 | -28.00 | -935.00 | -922.50 |
| EPS Basic Continuous Ops | 839.47 | -24.50 | -27.74 | -916.02 | -909.39 |
| EPS Diluted Total Ops | 858.00 | -24.50 | -28.00 | -935.00 | -922.50 |
| EPS Diluted Continuous Ops | 839.47 | -24.50 | -27.74 | -916.02 | -909.39 |
| EBITDA(a) | $-7,012 | $-6,330 | $-4,532 | $-4,240 | $-4,381 |